Pluri Inc. Files 10-Q for Period Ended December 31, 2023

TL;DR

<b>Pluri Inc. has filed its quarterly report (10-Q) for the period ending December 31, 2023, detailing its financial status and operations.</b>

AI Summary

Pluri Inc. (PLUR) filed a Quarterly Report (10-Q) with the SEC on February 12, 2024. Pluri Inc. filed a 10-Q report for the quarterly period ended December 31, 2023. The company is registered in Nevada and its principal executive offices are located in Haifa, Israel. Pluri Inc.'s common shares trade on The Nasdaq Capital Market under the symbol PLUR. The filing indicates Pluri Inc. is a non-accelerated filer and a smaller reporting company. The report covers the period following the company's name change from PLURISTEM THERAPEUTICS INC.

Why It Matters

For investors and stakeholders tracking Pluri Inc., this filing contains several important signals. This 10-Q filing provides investors with the latest financial and operational updates for Pluri Inc. for the specified quarter, crucial for assessing the company's performance and outlook. As a smaller reporting company and non-accelerated filer, this report offers insights into the financial health and regulatory compliance of Pluri Inc. within its specific classification.

Risk Assessment

Risk Level: low — Pluri Inc. shows low risk based on this filing. The filing is a standard quarterly report (10-Q) and does not contain immediate financial results or significant operational updates that would indicate a change in risk profile.

Analyst Insight

Monitor future filings for specific financial results and operational developments to assess Pluri Inc.'s progress in its business segments.

Key Numbers

• 20231231 — Quarterly Period End Date (Report period)
• 001-31392 — SEC File Number (Commission file number for Pluri Inc.)
• PLUR — Trading Symbol (Common Shares)

Key Players & Entities

• Pluri Inc. (company) — Filer name
• PLUR (company) — Trading Symbol
• December 31, 2023 (date) — Quarterly period ended
• The Nasdaq Capital Market (company) — Exchange where common shares are registered
• Nevada (jurisdiction) — State of incorporation
• Haifa, Israel (location) — Address of principal executive offices
• PLURISTEM THERAPEUTICS INC (company) — Former company name

FAQ

Risk Factors

• Filing Requirements [low — regulatory]: The company is required to file periodic reports such as this 10-Q with the SEC to comply with Section 13 or 15(d) of the Securities Exchange Act of 1934.

Key Dates

• 2023-12-31: Quarterly Period End — The reporting period for the 10-Q filing.
• 2024-02-12: Filing Date — Date the 10-Q was filed with the SEC.

Glossary

10-Q

A quarterly report required by the U.S. Securities and Exchange Commission (SEC) that provides a continuing disclosure by public companies. (This filing provides the most recent quarterly financial and operational information for Pluri Inc.)

Non-accelerated filer

A category of filer defined by the SEC based on public float and reporting history, generally indicating a smaller company with less stringent reporting requirements. (Indicates Pluri Inc.'s size and reporting status, which can influence investor expectations regarding disclosure depth.)

Smaller reporting company

A classification for companies with a public float below a certain threshold, allowing for scaled-down disclosure requirements. (Suggests Pluri Inc. is a smaller entity within the public markets, which may impact its growth potential and risk profile.)

Key Financial Figures

• $0.00001 — ch registered Common Shares, par value $0.00001 PLUR The Nasdaq Capital Market Securi
• $1 — ty $ 41,564 $ 50,797 (*) Less than $1 The accompanying notes are an integra

Filing Documents

• f10q1223_pluriinc.htm (10-Q) — 516KB
• f10q1223ex10-1_pluriinc.htm (EX-10.1) — 55KB
• f10q1223ex10-2_pluriinc.htm (EX-10.2) — 51KB
• f10q1223ex10-3_pluriinc.htm (EX-10.3) — 73KB
• f10q1223ex10-4_pluriinc.htm (EX-10.4) — 9KB
• f10q1223ex10-5_pluriinc.htm (EX-10.5) — 12KB
• f10q1223ex10-6_pluriinc.htm (EX-10.6) — 12KB
• f10q1223ex10-7_pluriinc.htm (EX-10.7) — 12KB
• f10q1223ex31-1_pluriinc.htm (EX-31.1) — 10KB
• f10q1223ex31-2_pluriinc.htm (EX-31.2) — 10KB
• f10q1223ex32-1_pluriinc.htm (EX-32.1) — 4KB
• f10q1223ex32-2_pluriinc.htm (EX-32.2) — 4KB
• 0001213900-24-012549.txt (&nbsp;) — 3154KB
• plur-20231231.xsd (EX-101.SCH) — 33KB
• plur-20231231_cal.xml (EX-101.CAL) — 29KB
• plur-20231231_def.xml (EX-101.DEF) — 140KB
• plur-20231231_lab.xml (EX-101.LAB) — 312KB
• plur-20231231_pre.xml (EX-101.PRE) — 147KB
• f10q1223_pluriinc_htm.xml (XML) — 281KB

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements. PLURI INC. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of December 31, 2023 U.S. DOLLARS IN THOUSANDS (Unaudited) INDEX Page Interim Condensed Consolidated Balance Sheets 1-2 Interim Condensed Consolidated Statements of Operations 3 Interim Condensed Consolidated Statements of Changes in Shareholders' Equity 4-5 Interim Condensed Consolidated Statements of Cash Flows 6-7 Notes to Interim Condensed Consolidated Financial Statements 8-17 i PLURI INC. INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) U.S. Dollars in thousands (except share and per share data) Note December 31, 2023 June 30, 2023 ASSETS CURRENT ASSETS: Cash and cash equivalents $ 5,468 $ 5,360 Short-term bank deposits 25,152 34,811 Restricted cash 373 269 Prepaid expenses and other current assets 1,259 969 Total current assets 32,252 41,409 LONG-TERM ASSETS: Restricted bank deposits 645 627 Severance pay fund 460 439 Property and equipment, net 788 688 Operating lease right-of-use asset 7,340 7,633 Long-term deposit and other long-term assets 79 1 Total long-term assets 9,312 9,388 Total assets $ 41,564 $ 50,797 The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 1 PLURI INC. INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) U.S. Dollars in thousands (except share and per share data) Note December 31, 2023 June 30, 2023 LIABILITIES AND SHAREHOLDERS' EQUITY CURRENT LIABILITIES Trade payables $ 1,104 $ 1,812 Accrued expenses 1,012 1,209 Operating lease liability 654 627 Accrued vacation and recuperation 779 873 Other accounts payable 981 1,100 Total current liabilities 4,530 5,621 LONG-TERM LIABILITIES Accrued severance pay 613 598 Operating lease liability 5,403 5,748 Loan from the European Investment Bank ("EIB") 4 24,401

View Full Filing

View this 10-Q filing on SEC EDGAR